Akumin (Akumin) Risk Assessment

View and export this data going back to 2017. Start your Free Trial

What is Akumin Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Akumin is: No Data: Cannot be evaluated.

Competitive Comparison of Akumin's Risk Assessment

For the Diagnostics & Research subindustry, Akumin's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Akumin's Risk Assessment Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Akumin's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Akumin's Risk Assessment falls into.

Akumin (OTCPK:AKUMQ) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Akumin Risk Assessment Related Terms

Thank you for viewing the detailed overview of Akumin's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Akumin (Akumin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Akumin Inc (OTCPK:AKUMQ) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

AKU:Canada

Address

8300 West Sunrise Boulevard, Plantation, FL, USA, 33322

Website

https://www.akumin.com

Akumin Inc is a Canada-based company that provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. It offers physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. The company's imaging procedures include MRI, CT, positron emission tomography, ultrasound, X-ray, mammography, and other diagnostic or interventional radiology procedures. It operates in two reportable business segments: radiology and oncology. The radiology segment acconts for majority revenue.

Executives

Ronald J. Bienias	officer: Chief Restructuring Officer	C/O AKUMIN INC.,, 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Stonepeak Gp Investors Holdings Manager Llc	10 percent owner, other: See Remarks	55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Stonepeak Gp Investors Upper Holdings Lp	10 percent owner, other: See Remarks	55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Stonepeak Gp Investors Holdings Lp	10 percent owner, other: See Remarks	55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Krishna Kumar	officer: See remarks	C/O AKUMIN INC., 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Lawrence Ross Sinclair	director	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
R. David Kretschmer	officer: See Remarks	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Murray Lee	director	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Scw Capital Management, Lp	10 percent owner	3131 TURTLE CREEK BLVD., SUITE 302, DALLAS TX 75219
Trinity Investment Group, Llc	10 percent owner	3131 TURTLE CREEK BLVD., #302, DALLAS TX 75219
Robert N. Cathey	10 percent owner	3131 TURTLE CREEK BLVD., #302, DALLAS TX 75219
John R. Wagner	10 percent owner	3838 OAK LAWN AVE., SUITE 450, DALLAS TX 75219
Paul Nelis	officer: Chief Information Officer	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Haichen Huang	director	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Matt Cameron	officer: See Remarks	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322